Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Icon Bioscience Appoints Clinical Development VP | Contract Pharma

What are you searching for?

Sign in
Breaking News

Icon Bioscience Appoints Clinical Development VP

Dr. Murahashi joins the management team

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Icon Bioscience, Inc. (IBI) has appointed Wendy Yee Murahashi, M.D. as vice president of Clinical Development. Dr. Murahashi will lead the company’s clinical development programs based on IBI’s Verisome drug delivery technology.
 
“As we near the completion of our pivotal Phase II/III trial evaluating IBI-10090 for the treatment of inflammation in patients undergoing cataract surgery, Wendy brings to IBI relevant clinical experience that will provide immediate value to IBI,” said William S. White, chief executive officer of Icon Bioscience. “She will also be a tremendous asset to IBI as we prepare in 2012 to initiate our clinical programs into new areas, including uveitis and glaucoma.”
 
Dr. Murahashi joins the company from Genentech/Roche, where she served as a medical director responsible for clinical activities for Lucentis. Previously she served as a clinical instructor at the Portland VA Hospital/Casey Eye Institute. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics